Founder of R-Pharma Repik sold a company supplying medical equipment to Russia

The company “R-pharm international”, which is engaged in the development of assets for the production and distribution of foreign medical equipment, has changed owners. On July 29, R-Pharma founder Alexei Repik sold shares in it to the group’s CEO Vasily Ignatiev (33%) and its CFO Andrei Smirnov (1%), according to SPARK-Interfax. Another 33% each now belongs to the CEO of R-Pharm Holding Olga Kuryanova and a certain Valeria Daeva. The latter, as of April 2020, was the founder of Valdai Management Company JSC, which market participants associate with Repik. The businessman himself did not answer the call of Vedomosti. Ignatiev, as well as representatives of the R-Pharm group and the state corporation VEB.RF (which holds all the shares of the co-owners of R-Pharm International as a pledge), declined to comment. It was not possible to contact Smirnov, Kuryanova and Daeva.

R-Pharm International was spun off from R-Pharm in 2017. It includes a number of companies that are engaged in different types of activities. For example, RTT Factory produces, under license from the American company Varian, medical equipment for oncology therapy and supplies foreign radiotherapy and radiosurgery systems to Russia, R-genproizvodstvo produces medical instruments and equipment, and R-Pharm Ventures owns a production and laboratory cluster “Bogorodskoe”, 28% of the center of laboratory diagnostics “Preobrazhenskoe” and 49% of the plant “R-pharm Novoselki”, which produces medicines in Yaroslavl. The revenue of R-Pharm International, according to SPARK-Interfax, doubled in 2021 compared to the previous year, amounting to 11.9 billion rubles, net profit also increased by 56% to 4.8 billion rubles